Unlock instant, AI-driven research and patent intelligence for your innovation.

Biological preparation for enhancing resistance of pigs to viral epidemic diseases

A biological agent and viral technology, applied in the field of biology, can solve the problems of high production cost of interferon, the impact of IFN antiviral effect, limited clinical trials, etc., and achieve the effect of easy purification, high activity and high quality

Active Publication Date: 2019-08-02
SHANDONG AGRICULTURAL UNIVERSITY
View PDF2 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] Although IFN can effectively inhibit the replication of many viruses, almost all DNA and RNA viruses have evolved a mechanism to evade the effects of host IFN, for example, the NS1 protein of influenza A virus can block the IFN-mediated activation in virus-infected cells. induced response, causing the antiviral effect of IFN to be affected
In addition, the high production cost of interferon is the biggest obstacle to the clinical application of interferon in veterinary medicine.
At present, the application of interferon in domestic animal husbandry production is still very small, basically limited to the stage of clinical trials

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Biological preparation for enhancing resistance of pigs to viral epidemic diseases
  • Biological preparation for enhancing resistance of pigs to viral epidemic diseases
  • Biological preparation for enhancing resistance of pigs to viral epidemic diseases

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0042] Example 1: pIFN-α, pIFN-γ and pIFN-λ1 gene sequence optimization and protein expression

[0043] In the early stage, we connected the pIFN-α, pIFN-γ and pIFN-λ1 genes to the eukaryotic expression system (insect cell baculovirus expression system), transfected Sf9 cells for expression, and selected Sf9 cells in good condition to inject 1×10 6 The cell / mL density was laid on a 6-well plate, and the DNA transfection was carried out when the cell density was about 70%. According to the instructions of X-tremeGENE HP DNA TransfectionReagent, each well was transfected with 2 μg of DNA, mixed well, at 37°C, 5% CO 2 Cultivate in an incubator for 24 hours, observe the state of the cells until the cells become larger. The supernatant was collected, and the obtained recombinant virus was blindly passed for 3 generations, and then the virus was collected. The obtained recombinant virus was used to infect sf9 cells, and verified by IFA and Western blot. The results showed that rec...

Embodiment 2

[0044] Example 2: pIFN-α, pIFN-γ, pIFN-λ1 stimulated antiviral gene expression detection

[0045]In order to verify the antiviral activity of the obtained pIFN-α, pIFN-γ, and pIFN-λ1, the expression of antiviral genes induced by them was detected first. Select PK-15 / CRL-2843 cells in good condition to 2.7×10 5 The cell / mL density was spread on a 24-well plate, and the cell density was equal to a monolayer for pIFN induction. Dilute pIFN, add 100 μl to each well, and store pIFN-α at 37°C, 5% CO 2 Cultivate in an incubator for 12 hours; pIFN-γ and pIFN-λ1 at 37°C, 5% CO 2 Cultivate in the incubator for 22h. The old cell culture medium was discarded, the cells were washed with pre-cooled PBS, the cells were lysed by adding RNAiso, and the cellular RNA was extracted and reverse-transcribed for quantitative PCR verification (see Table 1 for primers used in quantitative PCR).

[0046] The results of fluorescence quantification showed that in PK-15 cells, the dilution of pIFN-α w...

Embodiment 3

[0051] Example 3: The optimal inoculation dose of VSV / PRV infecting PK15 / CRL-2843 cells.

[0052] In the present invention, the antiviral effects of pIFN-α, pIFN-γ, and pIFN-λ1 are tested using the VSV system and porcine pseudorabies virus (PRV). Therefore, the priority is to detect the optimal inoculated dose of VSV and PRV infecting PK15 / CRL-2843 cells, and the selection standard is that 50% of the cells are infected as the optimal inoculated dose. Spread well-growing PK-15 cells and CRL-2843 cells in proportion on 24-well cell plates. After 12 hours, PK15 cells were inoculated with VSV / PRV at 1, 0.5, 0.1, and 0.01 MOI, and CRL-2843 cells were inoculated at 1 MOI. , 2, 3, 4, 5, 6, 7 MOI for inoculation, 12 hours after the virus infected the cells, take out the cell plate from the cell culture incubator, wash it twice with PBS, add trypsin to each well for digestion, and digest in the cell incubator for 5 min , add DMEM containing FBS, stop digestion, collect into 1.5mL EP t...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a biological preparation for enhancing resistance of pigs to viral epidemic diseases. According to the biological preparation for enhancing the resistance of the pigs to the viral epidemic diseases, by meas of a Bac-To-Bac insect baculovirus expression system, three different kinds of pocine interferon (pIFN):pIFN-alpha, pIFN-gamma and pIFN-lambda1 with high quality and high activity is obtained, and on the basis of optimizing antiviral activity conditions of the three kinds of pIFN, according to different ratios, combined application is conducted to obtain the optimalratio of the antiviral activity of combined application of the three kinds of pIFN. The antiviral activity of combined application of the three kinds of pIFN is improved by 10-1000 times compared withthat of single application of the three kinds of pIFN. The biological preparation for enhancing the resistance of the pigs to the viral epidemic diseases can be developed into a succedaneum of biological preparations and antibiotics for enhancing porcine immunocompetence and resisting the viral epidemic diseases, so that a material base is provided for prevention and control of the porcine viralepidemic diseases, especially emerging or burst important epidemic diseases.

Description

technical field [0001] The invention relates to the technical field of biology, in particular to a biological preparation for enhancing pig resistance to viral diseases. Background technique [0002] Viral disease is currently the number one pathogen that harms pig farming, and it is mainly prevented and controlled through vaccine immunization. However, for new viruses or recurrent diseases caused by viral infections with highly mutated genomes, there is no vaccine or the immune effect of the vaccine is not ideal. For example: the African swine fever that appeared in 2018, there is no commercially available preventive vaccine and therapeutic drug; the highly pathogenic PRRSV that appeared in 2006 and the NADC30-like porcine reproductive and respiratory syndrome virus that appeared in 2013 are classic vaccine strains and highly pathogenic porcine reproductive and respiratory syndrome virus vaccines have a low cross-protection rate, resulting in unsatisfactory immune effects ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N15/866C12N15/21C12N15/22C12N15/23A61K38/21A61P31/12
CPCA61K38/21A61K38/212A61K38/215A61P31/12C07K14/555C07K14/56C07K14/57C12N15/86C12N2710/14043A61K2300/00
Inventor 肖一红丛芳源刘思当
Owner SHANDONG AGRICULTURAL UNIVERSITY
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More